CGON

CG Oncology is a drug development company working on a cancer treatment called cretostimogene for bladder cancer patients. The drug is still being tested in clinical trials (the later stages of testing before regulators decide whether to approve a drug for patients). The company is testing whether cretostimogene works for different types of bladder cancer, including cases where other treatments have failed. The company was founded in 2010 and is based in Dallas, Texas.